重组DNA：从传染病角度看 - Suppr

Suppr

超能文献

Recombinant DNA: an infectious disease perspective.

作者信息

Gorbach S L

出版信息

J Infect Dis. 1978 May;137(5):615-23. doi: 10.1093/infdis/137.5.615.

DOI:10.1093/infdis/137.5.615

PMID:351074

Abstract

摘要

相似文献

Recombinant DNA: an infectious disease perspective.

J Infect Dis. 1978 May;137(5):615-23. doi: 10.1093/infdis/137.5.615.

Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli.

J Infect Dis. 1978 May;137(5):624-9. doi: 10.1093/infdis/137.5.624.

Pathogenesis of urinary tract infections: host susceptibility and bacterial virulence factors.

Urology. 1988 Sep;32(3 Suppl):9-11.

Bacterial adherence in urinary tract infections caused by Escherichia coli.

Scand J Urol Nephrol. 1986;20(2):81-8. doi: 10.3109/00365598609040553.

[Uropathogenicity of E. coli].

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1989 Jan-Mar;34(1):43-8.

Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential.

Appl Environ Microbiol. 2009 Jan;75(1):184-92. doi: 10.1128/AEM.01324-08. Epub 2008 Nov 7.

Urinary tract infection due to laboratory-acquired Escherichia coli: relation to virulence.

Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):949-50. doi: 10.1136/bmj.282.6268.949-a.

Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.

Trends Microbiol. 2004 Sep;12(9):424-30. doi: 10.1016/j.tim.2004.07.005.

Transferable antibiotic resistance in Escherichia coli.

Proc R Soc Med. 1971 May;64(5):533-4. doi: 10.1177/003591577106400530.

The spectrum of infections and pathogenic mechanisms of Escherichia coli.

Adv Intern Med. 1988;33:231-52.

引用本文的文献

Safety of lacto-N-tetraose (LNT) produced by a derivative strain ( K-12 MG1655 INB_LNT_01) of K-12 MG1655 (ATCC 700926) as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2025 Aug 13;23(8):e9610. doi: 10.2903/j.efsa.2025.9610. eCollection 2025 Aug.

Safety of lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2023 Dec 1;21(12):e8412. doi: 10.2903/j.efsa.2023.8412. eCollection 2023 Dec.

Safety of 3'-Sialyllactose (3'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2020 May 14;18(5):e06098. doi: 10.2903/j.efsa.2020.6098. eCollection 2020 May.

Safety of 6'-Sialyllactose (6'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2020 May 14;18(5):e06097. doi: 10.2903/j.efsa.2020.6097. eCollection 2020 May.

Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of K-12 DH1 as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2023 Jun 8;21(6):e08026. doi: 10.2903/j.efsa.2023.8026. eCollection 2023 Jun.

Safety and efficacy of a feed additive consisting of concentrated liquid l-lysine, l-lysine monohydrochloride and concentrated liquid l-lysine monohydrochloride produced by NITE BP-02917 for all animal species (Metex NoovistaGo).

EFSA J. 2022 Oct 25;20(10):e07612. doi: 10.2903/j.efsa.2022.7612. eCollection 2022 Oct.

Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2021 Jun 30;19(6):e06662. doi: 10.2903/j.efsa.2021.6662. eCollection 2021 Jun.

Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2019 Jun 11;17(6):e05717. doi: 10.2903/j.efsa.2019.5717. eCollection 2019 Jun.

Safety of lacto--tetraose (LNT) as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA J. 2019 Dec 3;17(12):e05907. doi: 10.2903/j.efsa.2019.5907. eCollection 2019 Dec.

Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Clin Microbiol Rev. 2008 Jul;21(3):403-25. doi: 10.1128/CMR.00014-08.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验